Bond.az White LogoBond.az Black Logo

Jefferies downgrades Lanxess stock rating

Jefferies downgraded Lanxess to Underperform with a EUR16 target. Stock at $20.04. Weak chemicals market, Iran conflict impact, and demand risks ahead.

Chloe Hall
ByChloe Hall- Senior Editor
|
0

Jefferies downgraded Lanxess AG (XETRA:LXS) from Hold to Underperform on Tuesday, lowering the price target to EUR16.00 from EUR17.00. The stock currently trades at $20.04.

European chemicals conditions remain weak in early 2025, with soft end markets and intense Asian competition. Utilization rates stay low and upstream pricing under pressure.

The Iran conflict in March shifted dynamics, reducing Asian exports to Europe and boosting pricing power with hikes up to 50%. The stock has risen 53% since its trough but remains 36% down over the past year.

Jefferies warns of potential demand destruction in H2 2026 due to higher energy costs. The firm forecasts FY2026 EBITDA of EUR477 million, 5% below guidance midpoint.

More News
Yesterday / 20:01
|
493

Relay Therapeutics Stock Upgrade Boosts Price

Relay Therapeutics stock upgraded by Jones Trading to Buy with $20 target after positive zovegalisib trial data.

0
Yesterday / 19:51
|
929

SandRidge Energy Stock Rating Upgraded to Hold

Freedom Broker upgraded SandRidge Energy to Hold after strong Q1 2026 results. Dividend increased by 8.3% to $0.13 per share.

0
Yesterday / 19:30
|
676

Inuvo PT Cut to $2.50 After Weak Q1

Freedom Broker cut Inuvo's price target to $2.50 after weak Q1 results. Stock fell 20% as the company transitions to IntentKey AI platform. Analysts predict profitability this year.

0
Yesterday / 18:51
|
524

CoreWeave Stock Rises on AI Demand Outlook

Evercore ISI reaffirms Outperform for CoreWeave. AI demand drives positive outlook for the company.

0
Yesterday / 18:32
|
682

Jefferies Cuts Home Depot Price Target

Jefferies cuts Home Depot price target to $361 from $454, maintaining Buy rating. New target offers 20% upside from current price.

0
Yesterday / 15:23
|
845

Legence Price Target Raised on AI Data Center Demand

Tigress Financial raises Legence price target to $125 on AI data center demand, citing record backlog and growth acceleration.

0
Yesterday / 15:01
|
898

Truist Raises Acushnet Target to $97

Truist Securities boosts Acushnet price target to $97, citing healthy trends. Hold rating maintained. Read more on Bond.az.

0
Yesterday / 15:00
|
739

Bill.com price target cut to $45 on take rate outlook

Truist Securities cuts Bill.com price target to $45 from $46, maintains Buy rating. Updated model reflects slower take rate expansion and cost-cutting measures.

0
Yesterday / 14:53
|
874

Piper Sandler Reiterates Boston Scientific Buy Rating

Piper Sandler reiterated an Overweight rating on Boston Scientific. Agent DCB drives growth; stock undervalued per Bond.az.

0
Yesterday / 14:52
|
437

Piper Sandler Reiterates Overweight on Climb Bio

Piper Sandler reiterates Overweight on Climb Bio. IgAN opportunity and CLYM116 outlook.

0
Yesterday / 14:51
|
547

Piper Sandler cuts e.l.f. Beauty target to $60

Piper Sandler cuts e.l.f. Beauty price target to $60 from $85, maintains Neutral rating. Stock trades at $53.23 near 52-week low.

0
Yesterday / 12:32
|
795

Morgan Stanley Reiterates Home Depot Rating on Execution

Morgan Stanley reiterates Overweight rating on Home Depot with $420 target, citing solid execution in a growthless housing market.

0
...
Jefferies downgrades Lanxess stock rating | Bond.az